|
WO2007106534A2
|
|
Selective amplification of minority mutations using primer blocking high-affinity oligonucleotides
|
|
AU2003286555A8
|
|
Phosphodiester inhibitors and nitric oxide modulators for treating peyronie's disease, arteriosclerosis and other fibrotic diseases
|
|
AU2003214804A1
|
|
Diagnosis and therapy of antibody-mediated inflammatory autoimmune disorders
|
|
US6936426B2
|
|
Detection of antibody mediated inflammatory auto-immune disorders
|
|
US6708052B1
|
|
Method and apparatus for cardiac imaging with minimized cardiac motion artifact
|
|
WO0156463A1
|
|
Method of monitoring conjunctival systemic parameters
|
|
US6585971B1
|
|
Recombinant α-L-iduronidase, methods for producing and purifying the same and methods for treating disease caused by deficiencies thereof
|
|
US6660833B1
|
|
Respiratory distress syndrome therapy with peptide analogs of human SP-B
|
|
US6426208B1
|
|
Recombinant α-L-iduronidase, methods for producing and purifying the same and methods for treating diseases caused by deficiencies thereof
|
|
EP1078075A2
|
|
Recombinant (alpha)-l-iduronidase, methods for producing and purifying the same and methods for treating diseases caused by deficiencies thereof
|
|
US6195409B1
|
|
Automatic scan prescription for tomographic imaging
|
|
EP1056465A1
|
|
Antimicrobial peptides and derived metapeptides
|
|
US6133281A
|
|
NMDA receptor blockers in the therapy of urogenital disease
|
